An in vivo tumor model expressing green fluorescent protein for the investigation of metastasis

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 705-712

  Thews, Oliver ^a   Lambert, Christine ^b   Kelleher, Debra K ^a   Biesalski, Hans K ^b   Vaupel, Peter ^a   Frank, Juergen ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Experimental tumor; Green fluorescent protein; Metastasis; Tumor cell detection

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; LUNG; LYMPH NODE; METABOLISM; METASTASIS; PATHOLOGY; PHASE CONTRAST MICROSCOPY; POLYMERASE CHAIN REACTION; RAT; SARCOMA;

ANIMALS; DNA; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LIVER; LUNG; LYMPH NODES; MICROSCOPY, PHASE-CONTRAST; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; RATS; SARCOMA, EXPERIMENTAL; TRANSFECTION;

EID: 24344498323     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Höckel M and Vaupel P: Tumor hypoxia: definitions and current clinical, biological, and molecular aspects. J Natl Cancer Inst 93: 266-276,2001.
2. Cairns RA, Kalliomäki T and Hill RP: Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61: 8903-8908,2001.
3. Rofstad EK: Microenvironment-induced cancer metastasis. Int J Radiat Biol 76: 589-605, 2000.
4. Claffey KP and Robinson GS: Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev 15: 165-176, 1996.
5. Dachs GU and Tozer GM: Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 36: 1649-1660, 2000.
6. Rofstad EK and Halsor EF: Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interieukin 8. Br J Cancer 86: 301-308, 2002.
7. Graham CH, Forsdike J, Fitzgerald CJ and Macdonald Goodfellow S: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80: 617-623, 1999.
8. Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K and Graff BA: Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinasetype plasminogen activator receptor. Cancer Res 62: 1847-1853, 2002.
9. Weinmann M, Thews O, Schroeder T and Vaupel P: Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size. Br J Cancer 86: 1355-1361,2002.
10. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW and Mueller-Klieser W: Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 349-353, 2001.
11. Walenta S, Welterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK and Mueller Klieser W: High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60: 916-921,2000.
12. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, Hill SA, Parkins C. Chaplin DJ, Presta M and Denekamp J: Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 80: 724-732, 1999.
13. Butler TP and Gullino PM: Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35: 512-516, 1975.
14. Chambers AF, Naumov GN, Vantyghem SA and Tuck AB: Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res 2: 400-407, 2000.
15. Condeelis JS, Wyckoff J and Segall JE: Imaging of cancer invasion and metastasis using green fluorescent protein. Eur J Cancer 36: 1671-1680, 2000.
16. Hoffman RM: Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359, 1999.
17. Vaupel P and Mueller-Klieser W: Cell line and growth site as relevant parameters governing tumor tissue oxygenation. Adv Exp Med Biol 200: 633-643, 1986.
18. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin DJ, Double JA, Embleton J, Newell D, Raymond R, Stables J, Stephens T and Wallace J: United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (2nd edition). Br J Cancer 77: 1-10, 1998.
19. Coralli C, Cemazar M, Kanthou C, Tozer GM and Dachs GU: Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res 61: 4784-4790, 2001.
20. Huang MS, Wang TJ, Liang CL, Huang HM, Yang JC, Yi-Jan H and Hsiao M: Establishment of fluorescent lung carcinoma metastasis model and its real-time microscopic detection in SCID mice. Clin Exp Metastasis 19: 359-368, 2002.
21. Ito S, Nakanishi H, Ikehara Y, Kato T, Kasai Y, Ito K, Akiyama S, Nakao A and Tatematsu M: Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int J Cancer 93: 212-217, 2001.
22. Li X, Wang J, An Z, Yang M, Baranov E, Jiang P, Sun F, Moossa AR and Hoffman RM: Optically imageable metastatic model of human breast cancer. Clin Exp Metastasis 19: 347-350, 2002.
23. Maeda H, Segawa T, Kamoto T, Yoshida H, Kakizuka A, Ogawa O and Kakehi Y: Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein. Prostate 45: 335-340,2000.
24. Shintani S, Mihara M, Nakahara Y, Aida T, Tachikawa T and Hamakawa H: Lymph node metastasis of oral cancer visualized in live tissue by green fluorescent protein expression. Oral Oncol 38: 664-669, 2002.
25. Sun FX, Tohgo A, Bouvet M, Yagi S, Nassirpour R, Moossa AR and Hoffman RM: Efficacy of camptothecin analog DX-8951f (exatecan mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res 63: 80-85, 2003.
26. Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S and Hoffman RM: Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA 97: 1206-1211, 2000.
27. Zhang L, Yang N, Garcia JR, Mohamed A, Benencia F, Rubin SC, Allman D and Coukos G: Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am J Pathol 161: 2295-2309, 2002.
28. Rashidi B, Yang M, Jiang P, Baranov E, An Z, Wang X, Moossa AR and Hoffman RM: A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin Exp Metastasis 18:57-60, 2000.
29. Yang M, Baranov E, Wang JW, Jiang P, Wang X, Sun FX, Bouvet M, Moossa AR, Penman S and Hoffman RM: Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc Natl Acad Sci USA 99: 3824-3829, 2002.
30. Murphy BO, Joshi S, Kessinger A, Reed E and Sharp JG: A murine model of bone marrow micrometastasis in breast cancer Clin Exp Metastasis 19: 561-569, 2002.
31. Schmidt CM, Settle SL, Keene JL, Westlin WF, Nickols GA and Griggs DW: Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry. Clin Exp Metastasis 17: 537-544, 1999.
32. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A and Muschel RJ: Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6: 100-102, 2000.
33. Hoffman RM: Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis Rev 17: 271-277, 1998.
34. Naumov GN, Wilson SM, MacDonald JC, Schmidt EE, Morris VL, Groom AC, Hoffman RM and Chambers AF: Cellular expression of green fluorescent protein, coupled with highresolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112: 1835-1842, 1999.
35. Wyckoff JB, Jones JG, Condeelis JS and Segall JE: A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60: 2504-2511, 2000.
36. Moore A, Sergeyev N, Bredow S and Weissleder R: A model system to quantitate tumor burden in locoregional lymph nodes during cancer spread. Invasion Metastasis 18: 192-197, 1998.
37. Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR and Hoffman RM: Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534-1540,2002.
38. Kan Z and Liu TJ: Video microscopy of tumor metastasis: using the green fluorescent protein (GFP) gene as a cancer-cell-labeling system. Clin Exp Metastasis 17: 49-55, 1999.
39. Lee NC, Bouvet M, Nardin S, Jiang P, Baranov E, Rashidi B, Yang M, Wang X, Moossa AR and Hoffman RM: Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model. Clin Exp Metastasis 18: 379-384, 2000.
40. Steinbauer M, Guba M, Cernaianu G, Kohl G, Cetto M, Kunz-Schughart LA, Geissler EK, Falk W and Jauch KW: GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin Exp Metastasis 20: 135-141,2003.
41. 2 supply. Acta Oncol 34: 291-295, 1995.